Insider · CIK 0001643071

Pande Atul

Reports to the SEC for 3 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001643071

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-28	IMVTImmunovant, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$8.43	+$12.6K	118,231
2026-08-28	IMVTImmunovant, Inc.S Sale	Director	SSale	−1,500 sh	$43.27	−$64.9K	116,731
2026-08-28	IMVTImmunovant, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	65,181
2026-07-24	IMVTImmunovant, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$8.43	+$12.6K	118,231
2026-07-24	IMVTImmunovant, Inc.S Sale	Director	SSale	−1,500 sh	$39.80	−$59.7K	116,731
2026-07-24	IMVTImmunovant, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	66,681
2026-06-26	IMVTImmunovant, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$8.43	+$12.6K	118,231
2026-06-26	IMVTImmunovant, Inc.S Sale	Director	SSale	−1,500 sh	$38.01	−$57K	116,731
2026-06-26	IMVTImmunovant, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	68,181
2026-06-15	IMVTImmunovant, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$8.43	+$12.6K	118,231
2026-06-15	IMVTImmunovant, Inc.S Sale	Director	SSale	−1,500 sh	$34.02	−$51K	116,731
2026-06-15	IMVTImmunovant, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	69,681
2026-05-20	IMVTImmunovant, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$8.43	+$50.6K	122,731
2026-05-20	IMVTImmunovant, Inc.S Sale	Director	SSale	−6,000 sh	$32.00	−$192K	116,731
2026-05-20	IMVTImmunovant, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	270,252
2026-04-07	IMVTImmunovant, Inc.A Award	Director	AAward	+13.9K sh	—	—	116,731
2026-04-07	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,061 sh	—	—	7,061
2025-04-01	IMVTImmunovant, Inc.A Award	Director	AAward	+16.2K sh	—	—	102,851
2025-04-01	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,600 sh	—	—	7,600
2024-12-02	IMVTImmunovant, Inc.S Sale	Director	SSale	−7,750 sh	$28.54	−$221K	86,663
2024-04-02	IMVTImmunovant, Inc.A Award	Director	AAward	+11.3K sh	—	—	94,413
2024-04-02	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,690 sh	—	—	4,690
2024-03-18	Karuna Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−990 sh	$330.00	−$327K	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	$232.41	−$2.91M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,500 sh	$201.99	−$1.72M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	$227.04	−$1.14M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,904 sh	$92.30	−$176K	0
2023-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−4,129 sh	$38.80	−$160K	91,379
2023-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−3,374 sh	$39.82	−$134K	88,005
2023-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−4,847 sh	$40.46	−$196K	83,158
2023-06-20	Karuna Therapeutics, Inc.A Award	Director	AAward	+990 sh	—	—	990
2023-06-20	Karuna Therapeutics, Inc.Option (right to buy)A Award	Director	AAward	+1,904 sh	—	—	1,904
2023-04-12	IMVTImmunovant, Inc.A Award	Director	AAward	+12.5K sh	—	—	95,508
2023-04-12	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.3K sh	—	—	16,260
2022-09-30	IMVTImmunovant, Inc.P Purchase	Director	PPurchase	+15K sh	$5.60	+$84K	20,000
2022-08-17	IMVTImmunovant, Inc.A Award	Director	AAward	+21.1K sh	—	—	82,985
2022-08-17	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31.7K sh	—	—	31,668
2022-06-15	Karuna Therapeutics, Inc.Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2022-02-01	Karuna Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$16.00	+$40K	2,500
2022-02-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$110.80	−$277K	0
2022-02-01	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	0
2022-01-10	IMVTImmunovant, Inc.A Award	Director	AAward	+21.7K sh	—	—	61,926
2022-01-10	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+71.5K sh	—	—	208,973
2022-01-03	Karuna Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$16.00	+$40K	2,500
2022-01-03	Karuna Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$130.44	−$326K	0
2022-01-03	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	2,500
2021-12-01	Karuna Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$16.00	+$40K	2,500
2021-12-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$127.73	−$319K	0
2021-12-01	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	5,000
2021-11-01	Karuna Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$16.00	+$40K	2,500

Recent filings

Accepted (ET)
Aug 284
Pande Atul0001764013-26-000103
SEC(opens sec.gov)
Jul 244
Pande Atul0001643071-26-000007
SEC(opens sec.gov)
Jun 264
Pande Atul0001764013-26-000071
SEC(opens sec.gov)
Jun 164
Pande Atul0001764013-26-000069
SEC(opens sec.gov)
May 204
Pande Atul0001643071-26-000004
SEC(opens sec.gov)
Apr 94
Pande Atul0001764013-26-000046
SEC(opens sec.gov)
Apr 34
Pande Atul0001764013-25-000047
SEC(opens sec.gov)
Dec 44
Pande Atul0001764013-24-000200
SEC(opens sec.gov)

Companies

Address

C/O IMMUNOVANT, INC. 1000 PARK FORTY PLAZA, SUITE 210

DURHAM, NC, 27713